Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2022-02-17 Regulatory Filings
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new AI technology product called NetraPlacebo by Nurosene Health Inc. It discusses the technology's application in clinical trials and includes forward-looking statements. There is no indication of financial results, regulatory filings, management changes, or shareholder voting results. The content is promotional and informational about a new product and partnership, typical of a general corporate announcement or regulatory news service release. The document length is 7,916 characters, which is relatively short and does not contain financial statements or detailed financial data. Therefore, it does not qualify as an Annual Report, Interim Report, Earnings Release, or similar financial filing. It also does not fit into categories like M&A, Board changes, or Dividend announcements. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements and press releases that do not fit other specific categories.
2022-02-17 English
News release - English.pdf
Regulatory Filings
2022-02-10 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a detailed pricing supplement for a structured note issuance by the Canadian Imperial Bank of Commerce (CIBC). It includes specific terms about the securities offered, pricing, commissions, issuance details, index references, coupon payments, and redemption conditions. The document is a supplement to a base prospectus and is focused on the capital raising and issuance of financial instruments. It is not a financial report, earnings release, or management discussion. It is a detailed update related to capital markets activity, specifically the issuance of structured notes. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement but a substantive update on financing terms.
2022-02-07 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Nurosene Health Inc. It announces the resignation of a director, Kirstine Stewart, which is a change in the company's board of directors. The document includes a detailed description of the change and references a press release. The form and content indicate it is a regulatory filing specifically reporting a material change related to board/management information. Given the nature of the content (board resignation) and the form type (Material Change Report), the most appropriate classification is 'Board/Management Information' (MANG). The document length is 4520 characters, which is sufficient to be the report itself, not just an announcement. Therefore, the classification is MANG with high confidence.
2022-02-07 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing a change in the company's board of directors, specifically the resignation of a director. It does not contain financial data, audit information, or detailed reports. It is not an earnings release, annual report, or any form of financial or regulatory filing. The key content is about management changes, which fits the category of Board/Management Information (MANG). The document length is 3711 characters, which is consistent with a typical announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2022-02-05 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2022-01-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.